CHAMBERS MICHAEL ANDREW purchased 15.0% of their position (37.04K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $4.96M — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/20/2024ACC: 0000950170-24-098859
Director
Since Jun 2022
+37.04K
Net shares
Net buyer
$4.96M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
37.04K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+13.11K
Price / share
$133.07
Trade value
$1.74M
% of position
5.3%
8/16/2024
247K→260.10K
Common Stock
Indirect
Shares
+18.28K
Price / share
$134.06
Trade value
$2.45M
% of position
7.0%
8/16/2024
260.10K→278.39K
Common Stock
Indirect
Shares
+5.65K
Price / share
$134.66
Trade value
$760.56K
% of position
2.0%
8/16/2024
278.39K→284.03K
Total
Net shares
+37.04K
Net value
$4.96M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/16/2024 | P · Purchase | +13.11K | $133.07 | $1.74M | 5.3% | 247K | 260.10K |
| Common Stock Indirect | 8/16/2024 | P · Purchase | +18.28K | $134.06 | $2.45M | 7.0% | 260.10K | 278.39K |
| Common Stock Indirect | 8/16/2024 | P · Purchase | +5.65K | $134.66 | $760.56K | 2.0% | 278.39K | 284.03K |
| Total | +37.04K | $4.96M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned8.28K
Total
8.28K direct8.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.28K | Direct |
| Total | 8.28K | 8.28K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported